Related Experiment Videos
Graft persistence effectively induces and maintains donor-specific unresponsiveness
H Nishinaka1, Y Nakafusa, T Hirano
1Department of Surgery I, Kyushu University Faculty of Medicine, Fukuoka, Japan.
The Journal of Surgical Research
|March 1, 1997
Summary
Persistent cardiac allografts, not microchimerism, better induce donor-specific unresponsiveness with FK506. Graft persistence under immunosuppression is key for long-term transplant survival.
Area of Science:
- Transplantation immunology
- Immunosuppression strategies
Background:
- Investigating the role of the graft as an alloantigen in inducing and maintaining donor-specific prolongation of allograft survival.
- Utilizing a short course of FK506 (tacrolimus) treatment in a rat heart transplantation model.
Purpose of the Study:
- To evaluate the graft's role as an alloantigen in FK506-mediated allograft survival.
- To compare the effectiveness of graft persistence versus microchimerism in inducing unresponsiveness.
Main Methods:
- Administered FK506 (3 mg/kg/day for 7 days) post-transplant in WKA/Qdj-to-LEW rat heart transplants.
- Performed sequential graft transplantation with varying removal times (Day 3, 7, 28) of the initial graft.
- Administered a second course of FK506 in some groups.
Main Results:
- Short-term FK506 treatment prolonged allograft survival (MST = 42.8 days).
- Graft removal on Day 7, but not Day 3, led to donor-specific prolongation of the second allograft survival.
- Persistent grafts, especially with a second FK506 course, were more effective in inducing long-term unresponsiveness than microchimerism alone.
Conclusions:
- Graft persistence is more effective than microchimerism in inducing and maintaining donor-specific unresponsiveness under FK506 immunosuppression.
- Residual donor antigen can act as a tolerizing antigen when supplemented with FK506.
- This model highlights the importance of graft presence in achieving transplant tolerance.